Zura Bio LTD 8-K filings

NASDAQ

2 Feb 2024

ZURA

8-K: Zura Bio Announces Participation in February Investor Conferences

Zura Bio's senior management will participate in several investor conferences throughout February to discuss their clinical-stage biotechnology programs.

NASDAQ

11 Jan 2024

ZURA

Zura Bio LTD

8-K: Zura Bio Presents Strategic Update at J.P. Morgan Healthcare Conference, Highlighting Dual-Pathway Approach

Zura Bio presented an update at the J.P. Morgan Healthcare Conference, emphasizing its dual-pathway approach to treating autoimmune diseases and its clinical pipeline.